In breast cancer (BRCA), overexpression of six dark kinases is associated with decreased overall survival (ALPK3, CSNK1A1L, CSNK2A3, NRK, POMK, and PSKH1) (Tables S2 and S3). Here, POMK is linked to invasive breast carcinoma.